Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald L Hamilton

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Pediatric Blood & Cancer|July 1, 2010
Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology GroupIan F Pollack, Ronald L Hamilton, Robert W Sobol, et al.
Journal of Translational Medicine|December 21, 2007
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomasHideho Okada, Frank S Lieberman, Kevin A Walter, et al.
Molecular Cancer Research : MCR|October 26, 2018
Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast CancerAhmed Basudan, Nolan Priedigkeit, Ryan J Hartmaier, et al.
Breast Cancer Research and Treatment|April 25, 2019
Examination and prognostic implications of the unique microenvironment of breast cancer brain metastasesMaria J Sambade, Grace Prince, Allison M Deal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant gliomaHideho Okada, Pawel Kalinski, Ryo Ueda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2015
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer PatientsPeilu Wang, Amir Bahreini, Rekha Gyanchandani, et al.
Cancer Research|June 16, 2019
Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine GliomasRobert F Koncar, Brittany R Dey, Ann-Catherine J Stanton, et al.
The Journal of Clinical Investigation|April 16, 2013
MERTK receptor tyrosine kinase is a therapeutic target in melanomaJennifer Schlegel, Maria J Sambade, Susan Sather, et al.
Journal of the National Cancer Institute|July 3, 2018
Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable TargetsDamir Varešlija, Nolan Priedigkeit, Ailís Fagan, et al.
Nature Genetics|March 10, 2009
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastomaPaul A Northcott, Yukiko Nakahara, Xiaochong Wu, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Pediatric Blood & Cancer|July 1, 2010
Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology GroupIan F Pollack, Ronald L Hamilton, Robert W Sobol, et al.
Journal of Translational Medicine|December 21, 2007
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomasHideho Okada, Frank S Lieberman, Kevin A Walter, et al.
Molecular Cancer Research : MCR|October 26, 2018
Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast CancerAhmed Basudan, Nolan Priedigkeit, Ryan J Hartmaier, et al.
Breast Cancer Research and Treatment|April 25, 2019
Examination and prognostic implications of the unique microenvironment of breast cancer brain metastasesMaria J Sambade, Grace Prince, Allison M Deal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant gliomaHideho Okada, Pawel Kalinski, Ryo Ueda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2015
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer PatientsPeilu Wang, Amir Bahreini, Rekha Gyanchandani, et al.
Cancer Research|June 16, 2019
Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine GliomasRobert F Koncar, Brittany R Dey, Ann-Catherine J Stanton, et al.
The Journal of Clinical Investigation|April 16, 2013
MERTK receptor tyrosine kinase is a therapeutic target in melanomaJennifer Schlegel, Maria J Sambade, Susan Sather, et al.
Journal of the National Cancer Institute|July 3, 2018
Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable TargetsDamir Varešlija, Nolan Priedigkeit, Ailís Fagan, et al.
Nature Genetics|March 10, 2009
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastomaPaul A Northcott, Yukiko Nakahara, Xiaochong Wu, et al.
Pageof 15